Beacon Co - Net Worth and Insider Trading
Beacon Co Net Worth
The estimated net worth of Beacon Co is at least $0 dollars as of 2025-04-11. Beacon Co is the 10% Owner of Infinity Pharmaceuticals Inc and owns about 0 shares of Infinity Pharmaceuticals Inc (INFIQ) stock worth over $0. Details can be seen in Beacon Co's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Beacon Co has not made any transactions after 2013-04-16 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Beacon Co
Beacon Co Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Beacon Co owns 1 companies in total, including Infinity Pharmaceuticals Inc (INFIQ) .
Click here to see the complete history of Beacon Co’s form 4 insider trades.
Insider Ownership Summary of Beacon Co
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
INFIQ | Infinity Pharmaceuticals Inc | 2013-04-16 | 10 percent owner |
Beacon Co Latest Holdings Summary
Beacon Co currently owns a total of 1 stock. Beacon Co owns 0 shares of Infinity Pharmaceuticals Inc (INFIQ) as of April 16, 2013, with a value of $0.
Latest Holdings of Beacon Co
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
INFIQ | Infinity Pharmaceuticals Inc | 2013-04-16 | 0 | 0.00 | 0 |
Holding Weightings of Beacon Co
Beacon Co Form 4 Trading Tracker
According to the SEC Form 4 filings, Beacon Co has made a total of 0 transactions in Infinity Pharmaceuticals Inc (INFIQ) over the past 5 years. The most-recent trade in Infinity Pharmaceuticals Inc is the sale of 5,708,282 shares on April 16, 2013, which brought Beacon Co around $219 Million.
Insider Trading History of Beacon Co
- 1
Beacon Co Trading Performance
GuruFocus tracks the stock performance after each of Beacon Co's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Beacon Co is 16.69%. GuruFocus also compares Beacon Co's trading performance to market benchmark return within the same time period. The performance of stocks bought by Beacon Co within 3 months outperforms 2 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Beacon Co's insider trading performs compared to the benchmark.
Beacon Co Ownership Network
Ownership Network List of Beacon Co
Ownership Network Relation of Beacon Co

Beacon Co Owned Company Details
What does Infinity Pharmaceuticals Inc do?
Who are the key executives at Infinity Pharmaceuticals Inc?
Beacon Co is the 10 percent owner of Infinity Pharmaceuticals Inc. Other key executives at Infinity Pharmaceuticals Inc include director & President & CEO Adelene Q Perkins , Chief Scientific Officer Stephane Peluso , and Chief Medical Officer Robert Jr. Ilaria .
Infinity Pharmaceuticals Inc (INFIQ) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Infinity Pharmaceuticals Inc (INFIQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Infinity Pharmaceuticals Inc (INFIQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Infinity Pharmaceuticals Inc (INFIQ)'s detailed insider trading history can be found in Insider Trading Tracker table.
Infinity Pharmaceuticals Inc Insider Transactions
Beacon Co Mailing Address
Above is the net worth, insider trading, and ownership report for Beacon Co. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Beacon Co's mailing address is: Jersey Channel Islands Xx Je4 9wg.